BDTX - Black Diamond Therapeutics Inc News Story
$24.33 0.2 0.7%
Last Trade - 20/04/21
| Market Cap | £624.4m |
| Enterprise Value | £399.1m |
| Revenue | £n/a |
| Position in Universe | 2952nd / 6849 |
BRIEF-Black Diamond Therapeutics Reports Q3 Loss Per Share Of $0.50
Tue 10th November, 2020 12:58pm
Nov 10 (Reuters) - Black Diamond Therapeutics Inc BDTX.O :
* BLACK DIAMOND THERAPEUTICS REPORTS THIRD QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* BLACK DIAMOND THERAPEUTICS - CASH, CASH EQUIVALENTS,
INVESTMENTS
OF $333.1 MILLION AS OF SEPT 30, EXPECTED TO BE SUFFICIENT TO
FUND OPERATIONS INTO 2023
* QTRLY LOSS PER SHARE $0.50
* Q3 EARNINGS PER SHARE VIEW $-0.52 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5xD60v
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Black Diamond Therapeutics Inc
See all news
